phase readout
saveNCT06983158: A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy
TERMINATEDupdated 20d ago
community read0 votes
Sponsor: Capsida Biotherapeutics, Inc.. Phase: PHASE1. Conditions: Developmental and Epileptic Encephalopathy
view source ↗
comments(0)
5-min edit window · permanent after that